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 Abstract 
The present study aimed to investigate altered grey matter (GM) and functional 
connectivity (FC) in deep subcortical areas, like the thalamus and basal ganglia, and 
their relationship with cognitive impairment in multiple sclerosis (MS). Thirty-six 
patients were neuropsychologically assessed, classified as cognitive preserved (CP) and 
cognitive impairment (CI), and were compared with 18 healthy controls (HC). GM 
atrophy and FC were observed in 10 predefined functional areas of the thalamus and in 
six of basal ganglia. GM atrophy was prominent in the basal ganglia in CI patients 
compared to CP MS patients. Increased FC was observed between the right caudate and 
the bilateral orbitofrontal cortex in CI vs. CP patients. The discriminant and correlation 
analyses revealed that the enhanced FC observed between the right caudate and the 
orbitofrontal cortex was closely associated with cognitive impairment in MS patients. In 
conclusion, reduced GM volume and enhanced fronto-basal ganglia connectivity are 
related to cognition in MS patients.  
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 1. Introduction 
Neuroimaging studies have revealed that grey matter (GM) atrophy is the main 
neuroanatomical correlate of cognitive disability in MS patients [1]. The relationship 
between these two variables has been assessed primarily in cortical areas [2], but more 
recent studies have suggested that GM loss plays a key role in subcortical structures, 
such as the thalamus [3]. In contrast, the relationship between GM atrophy in other 
subcortical areas, such as basal ganglia, has been less studied [3]. 
The thalamus and basal ganglia form part of cortico-subcortical circuits, and alterations 
of functional connectivity (FC) in these circuits might be as relevant as GM atrophy in 
MS patients’ cognitive decline. Indeed some recent studies have shown that thalamic 
atrophy is accompanied by increased FC between the thalamus and several cortical 
regions, and that these thalamic dysfunctions correlate with MS patients’ cognitive 
decline [4; 5]. Conversely, the existence and possible significance of similar alterations 
in basal ganglia remain largely unexplored. 
In this background, and given the relevance of subcortical structures in cognition, we 
devised an exploratory study that aimed to: 1) describe the GM and FC differences 
between cognitive preserved (CP) and cognitive impaired (CI) MS patients in different 
thalamic subregions of functional significance; 2) describe GM and FC differences 
between CP and CI patients in basal ganglia; 3) identify which of these neuro-
anatomical and neuro-functional subcortical alterations are associated with cognitive 
performance in MS patients. 
 
 
 
 Methods 
Participants 
Eighteen healthy controls (HC), and 36 patients with clinically defined relapsing-
remitting (RR) MS, according to the revised Mc Donald criteria [6], were recruited from 
the Hospital General de Castellón and were assessed using the Brief Repeatable Battery 
of Neuropsychological Tests (BRB-N). Following the criteria used in previous studies 
[7], the patients who scored a standard deviation of 1.5 below the mean normative 
values in at least one BRB-N test were considered CI, while the rest were recruited as 
CP. Each participant obtained a global cognition Z score by averaging the Z scores that 
corresponded to all the subtests. The Matrix Reasoning Subtest (WAIS-III [8]) and the 
Fatigue Severity Scale [9] were also administered. The study was approved by the 
Ethics Standards Committees of the Hospital General and the Universitat Jaume I, both 
of Castellón.  
Magnetic Resonance Imaging (MRI) acquisition 
Anatomical high-resolution 3d sagittal MPRAGE T1 images were acquired using a 1.5 T 
scanner (Siemens Avanto, Erlangen, Germany, TR = 11 ms, TE = 4.9 ms, FOV = 24 cm, 
matrix = 256 x 224 x 176, voxel size = 1 x 1 x 1 mm). Functional (fMRI) resting-state 270 
volumes were recorded over 9 min using a gradient-echo T2*-weighted echo-planar 
imaging sequence (TR/TE = 2000/30 ms, matrix = 64 x 64 x 30, voxel size = 3.5 x 3.5 x 
4.02 mm, flip angle = 90º). During the resting sequence, participants were instructed to 
remain motionless and to relax with their eyes closed, to not fall asleep and to think of 
nothing in particular. 
Region of interest (ROI) creation 
 
 Sixteen independent ROIs were created in the MNI space. 6 ROIs corresponded to basal 
ganglia, specifically the left and right caudate, putamen and pallidum, were obtained by 
WFU Pickatlas (wfu_pickatlas:www.fmri.wfubmc.edu/download.htm). Thalamic ROIs 
were obtained with Zhang thalamic connectivity atlas included in the LEAD-DBS toolbox 
(http://www.lead-dbs.org/). This atlas divides the thalamus into five regions according to 
the cortical areas that are highly correlated with specific thalamic areas, obtained in a 
previous resting-state fMRI study [10]. We separated these thalamic ROIs into left-right to 
finally obtain 10 ROIs. All the ROIs were binarized and used in subsequent analyses (see 
Figure, 1. A). 
Voxel-Based Morphometry (VBM) analysis 
In all patients, T1-hypointense lesions were identified and filled with the Jim software 
(Version 5.0, Xinapse Systems, Northants., UK; http://www.xinapse.com) to reduce the 
influence of MS lesions and to exclude the misclassified pixels from the statistical 
analysis following the previously described steps [11]. 
Then lesion-filled images were reoriented along the AC-PC and pre-processed 
following an optimized VBM protocol with the Diffeomorphic Anatomical Registration 
Through Exponential Lie Algebra (DARTEL) included in SPM8 (Wellcome Trust 
Centre for Neuroimaging, London, UK). Pre-processing included image segmentation 
into GM, WM, and CFS tissues in a native space, spatial normalization to a population-
specific template and modulation (to ensure that the overall amount of GM tissue was 
preserved). GM volumes (in milliliters -ml-) from all the ROIs were extracted in each 
participant through the intersection between the GM modulated map and the binary map 
that corresponded to each one. 
Seed-Functional Connectivity (FC) analysis 
 The resting-state fMRI images were pre-processed using the DPARSF V4.3 tool [12] 
and included: discarding the first 10 functional volumes to achieve a signal equilibrium, 
slice timing correction, realignment to the first scan of each session, head motion 
correction, coregister, nuisance covariates regression to remove nonspecific sources of 
variance (including the 24-parameter head motion model, scrubbing regressors, white 
matter signal, CSF and global signal), spatial normalization with a resampled voxel size 
of 3 mm3 to the Montreal Neurological Institute (MNI) space, and spatial smoothing 
with an isotropic Gaussian kernel of 4-mm full width at half maximum (FWHM). Next 
temporal filtering (0.01 Hz - 0.08 Hz) was applied to the time series of each voxel to 
reduce the effect of low-frequency drifts and high-frequency noise. 
Subsequent seed-FC analyses were performed by averaging the time series from each 
ROI and correlating with the time series of each voxel in the brain. 
Statistical Analyses 
Between-group comparisons were made with the demographic, clinical and cognitive 
variables by one-way ANOVAs and Bonferroni’s post hoc test using SPSS v.23. The 
GM and FC differences between groups were assessed with separate analyses of 
variance (ANOVA) in SPSS and SPM8 by setting the significance level at p < 0.05, and 
were FWE cluster-corrected for the multiple comparisons in combination with a 
threshold of p < 0.001 at the uncorrected level. The effect size for each statistically 
significant comparison was estimated by calculating the corresponding Cohen’s d. 
Finally, SPSS v.23 was used to run a discriminant analysis to identify the single 
volumetric/FC variable that best characterised each experimental group (HC, CP or CI). 
Pearson’s correlation index was used to identify the most relevant predictors of 
cognitive status (global Z score) in MS patients. 
 
 Results 
The demographic, clinical and neuropsychological results are presented in Table 1. The 
between-group differences in GM volume and FC are described in Table 2 and Figure 1. 
B, C, D. To sort according to importance, many effect sizes of the between-group 
differences were used. Thus, the main differences in GM volume in the thalamic regions 
between HC and CP patients were observed in the left parietal-occipital nucleus 
(d=2.31) and in the left temporal nucleus (d=2.04), whereas the differences between 
groups HC and CI reached their largest size in the left somatosensorial (d=2.40), the left 
temporal nucleus (d=2.34) and the left parietal occipital nucleus (d=2.18). Finally, the 
most prominent differences found between groups CP and CI were observed in the FC 
between the right caudate and the bilateral orbitofrontal cortex (d=1.81) and, to a lesser 
extent, in the volumes of the right (d=1.16) and left (d=1.15) putamen. Therefore, the 
main differences between HC and MS patients seem to involve a reduced GM volume 
in specific thalamic regions of the left hemisphere, where the parietal occipital nucleus 
is the most relevant anatomical area. Conversely, increased FC between the right 
caudate and the bilateral orbitofrontal cortex was the most salient characteristic of the 
CI group compared to the CP one. 
These conclusions were confirmed by a linear discriminant analysis (see Text, 
Supplemental Digital Content 1, Figure, Supplemental Digital Content 2 and Table, 
Supplemental Digital Content 3), which yielded a first significant discriminant function 
that distinguished HC from the two patient subgroups (79.1% explained variance; 
Wilks’ lambda (12)= 0.136, p<0.000) which, in turn, identified the left Parietal-
Occipital nucleus as its best single proxy (total structure coefficient=0.603). The second 
discriminant function was also statistically significant (20.9% explained variance; 
Wilks’ lambda (5)= 0.552, p<0.000) and distinguished CP from CI. The FC between the 
 right caudate and the bilateral orbitofrontal cortex was the variable that showed the 
highest bivariate correlation with the second discriminant function (total structure 
coefficient =0.772).  
Finally, the relationship between the neuroanatomical and neurofunctional variables 
included in this study (Table 2) and MS patients’ cognitive status (global Z score) was 
assessed by Pearson’s correlation index. The FC between the right caudate and the 
bilateral orbitofrontal cortex emerged as both the most prominent (see Figure 2) and the 
inverse neural correlate of cognitive performance. Interestingly, the GM volumes of 
almost all the basal ganglia subregions, but not those of the thalamus, also correlated 
significantly and directly with the global Z scores.  
Discussion  
We confirmed the results of previous studies, which indicate that GM loss in the 
thalamus is involved with worse cognition in MS [3]. However, we extend these results 
by 1) also providing a functional subregional analysis of the thalamus and 2) showing 
that both the thalamus and basal ganglia are important subcortical areas to determine 
MS patients’ cognitive status. Specifically, both patient groups (the CI and also the CP 
group) showed structural and functional differences in the thalamus compared to HC. 
However, while the GM volume was significantly reduced in each thalamic subregion at 
the bilateral level in CI patients, these effects were statistically significant only in the 
left, but not the right, hemisphere in CP patients. The direct comparisons made between 
CI and CP patients yielded only a significant difference at the right somatosensorial 
nucleus level, which suggests that the subregional analyses of thalamic atrophy could 
uncover the subtle neuroanatomical alterations associated with cognitive decline in MS 
patients.  
 The differences between the two patient subgroups became more evident in basal 
ganglia. We highlight two results that we found between CP and CI patients: 1) we 
observed GM atrophy in the bilateral caudate and the putamen in CI compared to CP; 2) 
the reduced GM in the right caudate was accompanied by increased FC between this 
area and the bilateral orbitofrontal cortex in CI versus CP patients. Finally, we found 
that increased FC was the best variable to distinguish between CP and CI patients, and it 
also correlated negatively with cognitive performance (global Z score). As a whole, 
these results suggest that cognitive decline in MS patients is associated with alterations 
to the specific modules of previously described fronto-basal loops. In line with this, it is 
worth noting that current models conceive cortico-striatal function as being modular and 
hierarchically organised, which confers the caudate nucleus a primarily cognitive role 
[13; 14]. The reason for this is, while the putamen is connected primarily to primary 
sensory and motor areas, the caudate is connected to the frontal areas involved in the 
regulation of emotional and cognitive functions [15], and also because non-invasive 
measures of anatomical and functional connectivity in humans have demonstrated that 
caudate and executive frontal areas are clearly linked [14]. Therefore, the results of the 
present study agree with the proposed cognitive role of the caudate-frontal loop and 
highlight its importance in understanding cognitive decline in MS patients. 
In conclusion, this is the first study to reveal that deficiencies in basal ganglia and, more 
specifically, enhanced FC in the fronto-basal ganglia network, are related to cognitive 
impairment in MS. Future studies are needed to confirm these previous exploratory 
results.  
 
 
 
 Acknowledgements  
This study was sponsored by grants P1-1B2014-15 awarded by Universitat Jaume I and 
PSI2015-67285-R awarded by MINECO to Dr. Cristina Forn. 
  
 References 
1.  Messina S, Patti F. Gray Matters in Multiple Sclerosis: Cognitive Impairment 
and Structural MRI. Mult. Scler. Int. 2014; 2014: 1–9. 
2.  Filippi M, Rocca MA, Benedict RHB, DeLuca J, Geurts JJG, Rombouts SARB, 
et al. The contribution of MRI in assessing cognitive impairment in multiple 
sclerosis. Neurology 2010; 75 (23): 2121–8. 
3.  Bergsland N, Zivadinov R, Dwyer MG, Weinstock-Guttman B, Benedict RH. 
Localized atrophy of the thalamus and slowed cognitive processing speed in MS 
patients. Mult. Scler. J. 2015; 1–10. 
4.  Tewarie P, Schoonheim MM, Schouten DI, Polman CH, Balk LJ, Uitdehaag 
BMJ, et al. Functional brain networks: Linking thalamic atrophy to clinical 
disability in multiple sclerosis, a multimodal fMRI and MEG Study. Hum. Brain 
Mapp. 2015; 36 (2): 603–618. 
5.  Zhou F, Gong H, Chen Q, Wang B, Peng Y, Zhuang Y, et al. Intrinsic Functional 
Plasticity of the Thalamocortical System in Minimally Disabled Patients with 
Relapsing-Remitting Multiple Sclerosis. Front. Hum. Neurosci. 2016; 10: 2. 
6.  Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. 
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald 
criteria. Ann. Neurol. 2011; 69 (2): 292–302. 
7.  Louapre C, Perlbarg V, García-Lorenzo D, Urbanski M, Benali H, Assouad R, et 
al. Brain networks disconnection in early multiple sclerosis cognitive deficits: an 
anatomofunctional study. Hum. Brain Mapp. 2014; 35 (9): 4706–17. 
8.  Wechsler D. Escala de inteligencia de Wechsler para adultos. Madrid: TEA 
Ediciones; 2001.  
9.  Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale: 
application to patients with multiple sclerosis and systemic lupus erythematosus. 
Arch. Neurol. 1989; 46 (10): 1121–1123. 
10.  Zhang D, Snyder AZ, Fox MD, Sansbury MW, Shimony JS, Raichle ME. 
Intrinsic Functional Relations Between Human Cerebral Cortex and Thalamus. J. 
Neurophysiol. 2008; 100 (4): 1740–1748. 
11.  Gelineau-Morel R, Tomassini V, Jenkinson M, Johansen-Berg H, Matthews PM, 
 Palace J. The effect of hypointense white matter lesions on automated gray 
matter segmentation in multiple sclerosis. Hum. Brain Mapp. 2012; 33 (12): 
2802–14. 
12.  Chao-Gan Y, Yu-Feng Z. DPARSF: A MATLAB Toolbox for “Pipeline” Data 
Analysis of Resting-State fMRI. Front. Syst. Neurosci. 2010; 4: 13. 
13.  Postuma RB, Dagher A. Basal ganglia functional connectivity based on a meta-
analysis of 126 positron emission tomography and functional magnetic resonance 
imaging publications. Cereb. Cortex 2006; 16 (10): 1508–1521. 
14.  Grahn JA, Parkinson JA, Owen AM. The cognitive functions of the caudate 
nucleus. Prog. Neurobiol. 2008; 86 (3): 141–155. 
15.  Lehéricy S, Ducros M, Van De Moortele PF, Francois C, Thivard L, Poupon C, 
et al. Diffusion Tensor Fiber Tracking Shows Distinct Corticostriatal Circuits in 
Humans. Ann. Neurol. 2004; 55 (4): 522–529. 
 
  
 Table 1. Main demographic, clinical and neuropsychological characteristics of all 
participants. 
 HC 
(n=18) 
CP patients 
(n=18) 
CI patients 
(n=18) 
HC-CP HC-CI CP -CI 
Age (SD) 
[range] 
33.33 (9.49) 
[22-54] 
33.39 (7.03) 
[23-49] 
38.78 (9.74) 
[20-58] 
1.000 .211 .219 
Gender (Male/Female) 9/9 5/13 5/13 - - - 
Mean Education Years (SD) 
[range] 
13.61 (2.64) 
[8-16] 
12.22 (2.32) 
[8-16] 
11.67 (2.87) 
[8-15] 
.353 .091 1.000 
EDSS (SD) 
[range] 
- 1.56 (0.76) 
[0-3.5] 
3.14 (1.28) 
[1-6.5] 
-   - .000 ** 
Mean years disease duration (SD) 
[range] 
- 5.94 (4.53) 
[1-15] 
10.72 (7.69) 
[1-29] 
- - .031* 
FSS 31.78 
(10.15) 
31.33 (16.85) 37.67 
(13.92) 
1.000 .629 .534 
Manipulative IQ (Matrix WAIS-
III) 
107.22 
(9.74) 
103.89 
(10.92) 
99.17 (8.79) .945 .053 .470 
SDMT 59.06 
(11.22) 
60.61 (6.81) 39.72 
(11.79) 
1.000 .000 ** .000 ** 
PASAT 3 sec. 46.44 (9.87) 49.78 (6.44) 35.17 
(13.24) 
.999 .005 ** .000 ** 
SRT Long Term Storage 52.67 
(12.08) 
50.00 (6.79) 33.22 
(11.12) 
1.000 .000 ** .000 ** 
SRT Consistent Long Term 
Retrieval 
42.28 
(10.46) 
42.00 (8.29) 21.89 (9.77) 1.000 .000 ** .000 ** 
SRT Delayed Recall 9.94 (1.39) 9.78 (1.21) 5.89 (2.19) 1.000 .000 ** .000 ** 
10/36 SPART Long-Term 
Storage 
22.28 (4.55) 22.56 (3.33) 16.39 (4.23) 1.000 .000 ** .000 ** 
10/36 SPART Delayed Recall 7.94 (2.15) 7.61 (1.61) 5.61 (2.17) 1.000 .003 ** .012* 
Phonetic Fuency 12.89 (3.97) 14.56 (4.54) 10.72 (3.29) .639 .322 .016* 
 
Abbreviations: HC = Healthy Controls; CP = cognitive preserved; CI = cognitive 
impaired; EDSS = Expanded Disability Status Scale; FSS = Fatigue Severity Scale; IQ 
= Intelligence Quotient; SDMT = Symbol Digit Modalities Test; PASAT = Paced 
Auditory Serial Addition Test; SRT = Selective Reminding Test; SPART = Spatial 
Recall Test; ** = significantly different at p < 0.01; * = significantly different at p < 
0.05. 
  
  Table 2: Between-group differences in basal ganglia and thalamic volume. 
Descriptive data are expressed as means and standard deviations (in brackets). For the 
between-groups comparisons, the p values associated with the Bonferroni post hoc 
comparisons and the Cohen’s d values are provided. 
 HC 
(n=18) 
CP  
(n=18) 
CI  
(n=18) 
 
HC - CP 
 
HC - CI 
 
CP - CI 
Basal Ganglia GM volume (ml)       
L Caudate 4.70  (0.48) 4.66  (0.49) 4.07 (0.84) 1.000 .013 * (d=0.92) .020* (d=0.85) 
R Caudate 5.01  (0.59) 4.80  (0.62) 4.03  (0.91) 1.000 .000 ** (d=1.23) .008 ** (d=0.99) 
L Putamen 5.04  (0.85) 4.16  (0.97) 2.99  (1.07) 0.027* (d=0.96) .000 ** (d=2.12) .002 ** (d=1.15) 
R Putamen 4.94  (0.76) 4.63  (1.01) 3.42  (1.07) .986 .000 ** (d=1.63) .001 ** (d=1.16) 
L Pallidum 0.31  (0.11) 0.22  (0.07) 0.18  (0.06) 0.009** (d=0.98) .000 ** (d=1.47) .334 
R Pallidum 0.50  (0.11) 0.39  (0.11) 0.30  (0.12) 0.009** (d=0.99) .000 ** (d=1.74) .050 
Thalamus GM volume (ml)       
L Motor-Premotor nucleus 3.21  (0.39) 2.26  (0.66) 1.73  (0.82) .000** (d=1.75) .000 ** (d=2.30) .055 
R Motor-Premotor nucleus 2.55  (0.41) 2.17 (0.60) 1.72  (0.65) .151 .000 ** (d=1.53) .057 
L Parietal-Occipital nucleus 2.04  (0.20) 1.59 (0.19) 1.57  (0.23) .000 ** (d=2.31) .000 ** (d=2.18) 1.000 
R Parietal-Occipital nucleus 2.16 (0.24) 1.94  (0.32) 1.79  (0.37) .113 .002** (d=1.18) .456 
L Prefrontal nucleus 3.39 (0.39) 2.73  (0.44) 2.47 (0.57) .000 ** (d=1.59) .000 ** (d=1.88) .313 
R Prefrontal nucleus 2.28 (0.27) 1.99  (0.40) 1.79 (0.39) .068 .001 ** (d=1.46) .295 
L Somatosensorial nucleus 0.31 (0.05) 0.19 (0.10) 0.12 (0.10) .000 ** (d=1.52) .000 ** (d=2.40) .057 
R Somatosensorial nucleus 0.27 (0.06) 0.23  (0.09) 0.16 (0.08) .374 .000 ** (d=1.56) .023* (d=0.82) 
L Temporal nucleus 1.91 (0.21) 1.44  (0.25) 1.37 (0.25) .000 ** (d=2.04) .000 ** (d=2.34) 1.000 
R Temporal nucleus 1.26 (0.19) 1.15  (0.23) 1.00  (0.30) .573 .008 ** (d=1.03) .213 
Functional connectivity       
FC-R caudate- B orbitofrontal cortex 0.08 (0.09) 0.04 (0.11) 0.21 (0.06) 0.53 .001** (d=1.57) .000* (d=1.81) 
FC-R premotor-L cerebellum 0.16 (0.12) 0.04 (0.10) -0.01 (0.07) .002** (d=1.23) .000** (d=1.81) .591 
FC-R premotor-B cingulate 0.18 (0.10) 0.05 (0.08) 0.01 (0.11) .002** (d=1.44) .000** (d=1.65) .571 
FC R pallidum- R caudate 0.23 (0.11) 0.11 (0.10) 0.04 (0.11) 0.008** (d=1.14) 0.000** (d=1.72) .163 
 
Abbreviations: ml = millilitres; HC = healthy controls; CP = cognitive preserved; C =: 
cognitive impaired; L = left; R = right; B=Bilateral ** = significantly different at p < 
0.01; * = significantly different at p < 0.05. 
  
 Figure 1. Figure illustrating the regions of interest (ROIs) and between-group seed rs-
FC significant differences. A: ROIs corresponding to basal ganglia and the thalamus.  
B: reduction in FC between the right pallidum and the right caudate in CI patients 
versus HC; C: increased FC between the right caudate and the medial orbitofrontal 
cortex in CI patients versus CP patients; D: reduction in FC between the right 
motor/premotor thalamic nucleus and the bilateral middle cingulate gyrus and the left 
cerebellum in CI versus HC. 
Figure 2. Correlational heat map between the global Z score and the MRI structural and 
Functional Connectivity variables. Colours denote significance level and Pearson r 
coefficient values are provided in cells. 
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analyses. 
• Supplemental Digital Content 2. Figure illustrating the two-function plot of the 
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discriminating model. Note that although no strict correspondence between these 
two sets of coefficients exists, both indicate that the GM volume of the left 
parietal-occipital nucleus of the thalamus and the FC between the caudate and 
the orbitofrontal cortex are the most relevant variables of the obtained 
discriminant functions. Abbreviations: L: left; R: right, FC: functional 
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